Adverse Drug Reactions in Rheumatoid Arthritis Patients Taking Combination DMARDs

Journal Title: Journal of Medical Science And clinical Research - Year 2016, Vol 4, Issue 8

Abstract

Methods- It’s a prospective single centre controlled study. Patients of Reumatoid arthritis were divided into 2 study groups, Group-1 patients were given Methotrexate (MTX) oral weekly with Hydroxychloroquine oral daily. Group-2 patients were given Methotrexate (MTX) oral weekly with Salfasalazine oral daily in divided doses. Apart from the study medications, all patients were also given concomitant medications. The data was obtained from suspected ADRs reporting forms, between January 2014 to January 2015 from the Rheumatology OPD, Medicine department to the ADRs monitoring centre attached to department of Pharmacology under the Pharmacovigilance programme of India (PvPi). The reported ADRs were assessed for causality using WHO causality assessment scale. The severity was assessed using Hartwig and Siegel scale. Observations: 131 patients who entered the study, 68 were study assigned to receive Methotrexate and Hydroxychloroquine (Group I) and 63 to receive Methotrexate and Sulfasalazine. In the study, in total 99 ADRs were reported from 53 ADR Forms. Most common occurring ADRs were nausea and vomiting in both the treatment groups. Different adverse drug reactions like nausea, blurring of vision, hyperpigmentation of skin, anaemia, epigastric pain, breathlessness were observed amongst patients in group-1.Whereas in group-2 patients the nausea, diarrhoea, headache, hepatotoxicity and leucopenia were seen. Conclusions: DMARD’s combination cause more but tolerable adverse effects. Combination DMARD regimens are safe for use in Rheumatoid arthritis to control disease activity with tolerable, transient and reversible adverse effects

Authors and Affiliations

Paramjeet Singh

Keywords

Related Articles

Indications and Patterns of Upper Gastro Intestinal Endoscopy Findings among Patients Attending A Tertiary Care Hospital, Kolkata, India

Introduction: Upper Gastrointestinal (UGI) endoscopy has become part and parcel of investigation protocol in a patient with gastrointestinal diseases. With passage of time it has been transformed to a therapeutic modalit...

A Cross Sectional Study to Evaluate the Psychosocial and Health Challenges in School Students

Background: Students face many situations in school that may result in psychosocial and health problems and rather than for the school to be a source of positive socialization. The present study was aimed at determining...

Prevalence of different categories of COPD in a tertiary care teaching hospital in Kerala

Background: Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation. It should b...

Solitary Plasmacytoma of Scalp without Intra Cranial ExtensionA Cytological Rare Case Report

In this report we present an interesting rare case of solitary plasmacytoma of the scalp without bony erosion in a 52 year female. The clinicians suspected it to be a malignant tumor, but didn’t come to a conclusion as t...

Insulin Resistance: Alström Syndrome

Alström syndrome is a rare ciliopathy affecting about 1 in 1,000,000 individuals. It is characterized by cone-rod dystrophy, insulin resistance, diabetes mellitus, cardiomyopathy, renal & hepatic dysfunction, hearing los...

Download PDF file
  • EP ID EP214223
  • DOI -
  • Views 83
  • Downloads 0

How To Cite

Paramjeet Singh (2016). Adverse Drug Reactions in Rheumatoid Arthritis Patients Taking Combination DMARDs. Journal of Medical Science And clinical Research, 4(8), 12115-12124. https://europub.co.uk/articles/-A-214223